EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacokinetic barriers to oxfendazole flukicidal efficacy

Laura Ceballos iD, Candela Canton, Valeria Gayo, Laura Moreno, Carlos Lanusse, Luis Alvarez

PLOS One · 2026

DOI: 10.1371/journal.pone.0355551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Laura Ceballos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Farmacología Centro de Investigación Veterinaria de Tandil (CIVETAN), CONICET-UNCPBA-CICPBA, Facultad de Ciencias Veterinarias, UNCPBA…. Hauptthemen laut MEDLINE: Benzimidazoles, Fascioliasis, Anthelmintics, Sheep Diseases. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although oxfendazole (OFZ) has been traditionally used to control nematode parasites in domestic animals and more recently in human medicine, high efficacy against porcine cysticercosis and fasciolosis in both sheep and pigs has been observed when the drug is administered at higher dose levels. In this context, the plasma disposition kinetics and the pattern of drug accumulation in adult Fasciola hepatica was characterized in infected sheep orally treated with OFZ at either the nematodicidal dose of 5 mg/kg (OFZ 5 ) or at a higher dose of 30 mg/kg (OFZ 30 ) . OFZ was the main analyte detected in plasma of treated sheep. The systemic exposure (AUC 0–LOQ ) increased from 17.9 ± 3.71 µg.h/mL at the therapeutic dose to 85.4 ± 22.6 µg.h/mL with the highest dose treatment. The plasma Cmax value was approximately fourfold higher in the OFZ 30 compared to the OFZ 5 treated animals. The dose-related marked differences in OFZ systemic exposure were reflected in the accumulation into F. hepatica specimens, which was 332% higher in the OFZ 30 group (4.28 µg/g) than in the OFZ 5 group (0.99 µg/g). The data shown here demonstrate that increasing the OFZ dose is associated with enhanced plasma drug exposure and greater accumulation in the target trematode parasite, which helps to explain the enhanced efficacy of OFZ against adult liver flukes at the 30 mg/kg dose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzimidazolesFascioliasisAnthelminticsSheep DiseasesAnimalsSheepFasciola hepaticaFemaleDose-Response Relationship, Drug

Substanzen

oxfendazoleBenzimidazolesAnthelmintics

Autor:innen und Institutionen

  • Laboratorio de Farmacología Centro de Investigación Veterinaria de Tandil (CIVETAN), CONICET-UNCPBA-CICPBA, Facultad de Ciencias Veterinarias, UNCPBA, Campus Universitario, Tandil, Argentina.
  • Instituto DILAVE, 'Miguel C. Rubino', Montevideo, Uruguay.

ORCID-Profile: Laura Ceballos

Zitieren

APA

Ceballos, L., Canton, C., Gayo, V., Moreno, L., Lanusse, C., & Alvarez, L. (2026). Pharmacokinetic barriers to oxfendazole flukicidal efficacy. PLOS One. https://doi.org/10.1371/journal.pone.0355551

Vancouver

Ceballos L, Canton C, Gayo V, Moreno L, Lanusse C, Alvarez L. Pharmacokinetic barriers to oxfendazole flukicidal efficacy. PLOS One. 2026. doi:10.1371/journal.pone.0355551

BibTeX
@article{Ceballos2026,
  author = {Ceballos, Laura and Canton, Candela and Gayo, Valeria and Moreno, Laura and Lanusse, Carlos and Alvarez, Luis},
  title = {Pharmacokinetic barriers to oxfendazole flukicidal efficacy},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0355551}
}
Kostenlos starten →